Global Belimumab Market Growth 2022-2028
- LP 4768498
- 77 Pages
- January 2022
- Pharmaceuticals
The United States Belimumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Belimumab market, reaching US$ million by the year 2028. As for the Europe Belimumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Belimumab players cover GlaxoSmithKline, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Belimumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
400mg Injection
120mg Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drug Center
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GlaxoSmithKline
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Belimumab Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Belimumab by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Belimumab by Country/Region, 2017, 2022 & 2028
2.2 Belimumab Segment by Type
2.2.1 400mg Injection
2.2.2 120mg Injection
2.3 Belimumab Sales by Type
2.3.1 Global Belimumab Sales Market Share by Type (2017-2022)
2.3.2 Global Belimumab Revenue and Market Share by Type (2017-2022)
2.3.3 Global Belimumab Sale Price by Type (2017-2022)
2.4 Belimumab Segment by Application
2.4.1 Hospital
2.4.2 Drug Center
2.4.3 Clinic
2.4.4 Other
2.5 Belimumab Sales by Application
2.5.1 Global Belimumab Sale Market Share by Application (2017-2022)
2.5.2 Global Belimumab Revenue and Market Share by Application (2017-2022)
2.5.3 Global Belimumab Sale Price by Application (2017-2022)
3 Global Belimumab by Company
3.1 Global Belimumab Breakdown Data by Company
3.1.1 Global Belimumab Annual Sales by Company (2020-2022)
3.1.2 Global Belimumab Sales Market Share by Company (2020-2022)
3.2 Global Belimumab Annual Revenue by Company (2020-2022)
3.2.1 Global Belimumab Revenue by Company (2020-2022)
3.2.2 Global Belimumab Revenue Market Share by Company (2020-2022)
3.3 Global Belimumab Sale Price by Company
3.4 Key Manufacturers Belimumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Belimumab Product Location Distribution
3.4.2 Players Belimumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Belimumab by Geographic Region
4.1 World Historic Belimumab Market Size by Geographic Region (2017-2022)
4.1.1 Global Belimumab Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Belimumab Annual Revenue by Geographic Region
4.2 World Historic Belimumab Market Size by Country/Region (2017-2022)
4.2.1 Global Belimumab Annual Sales by Country/Region (2017-2022)
4.2.2 Global Belimumab Annual Revenue by Country/Region
4.3 Americas Belimumab Sales Growth
4.4 APAC Belimumab Sales Growth
4.5 Europe Belimumab Sales Growth
4.6 Middle East & Africa Belimumab Sales Growth
5 Americas
5.1 Americas Belimumab Sales by Country
5.1.1 Americas Belimumab Sales by Country (2017-2022)
5.1.2 Americas Belimumab Revenue by Country (2017-2022)
5.2 Americas Belimumab Sales by Type
5.3 Americas Belimumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Belimumab Sales by Region
6.1.1 APAC Belimumab Sales by Region (2017-2022)
6.1.2 APAC Belimumab Revenue by Region (2017-2022)
6.2 APAC Belimumab Sales by Type
6.3 APAC Belimumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Belimumab by Country
7.1.1 Europe Belimumab Sales by Country (2017-2022)
7.1.2 Europe Belimumab Revenue by Country (2017-2022)
7.2 Europe Belimumab Sales by Type
7.3 Europe Belimumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Belimumab by Country
8.1.1 Middle East & Africa Belimumab Sales by Country (2017-2022)
8.1.2 Middle East & Africa Belimumab Revenue by Country (2017-2022)
8.2 Middle East & Africa Belimumab Sales by Type
8.3 Middle East & Africa Belimumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Belimumab
10.3 Manufacturing Process Analysis of Belimumab
10.4 Industry Chain Structure of Belimumab
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Belimumab Distributors
11.3 Belimumab Customer
12 World Forecast Review for Belimumab by Geographic Region
12.1 Global Belimumab Market Size Forecast by Region
12.1.1 Global Belimumab Forecast by Region (2023-2028)
12.1.2 Global Belimumab Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Belimumab Forecast by Type
12.7 Global Belimumab Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Belimumab Product Offered
13.1.3 GlaxoSmithKline Belimumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
14 Research Findings and Conclusion
Table 1. Belimumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Belimumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 400mg Injection
Table 4. Major Players of 120mg Injection
Table 5. Global Belimumab Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Belimumab Sales Market Share by Type (2017-2022)
Table 7. Global Belimumab Revenue by Type (2017-2022) & ($ million)
Table 8. Global Belimumab Revenue Market Share by Type (2017-2022)
Table 9. Global Belimumab Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Belimumab Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Belimumab Sales Market Share by Application (2017-2022)
Table 12. Global Belimumab Revenue by Application (2017-2022)
Table 13. Global Belimumab Revenue Market Share by Application (2017-2022)
Table 14. Global Belimumab Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Belimumab Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Belimumab Sales Market Share by Company (2020-2022)
Table 17. Global Belimumab Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Belimumab Revenue Market Share by Company (2020-2022)
Table 19. Global Belimumab Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Belimumab Producing Area Distribution and Sales Area
Table 21. Players Belimumab Products Offered
Table 22. Belimumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Belimumab Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Belimumab Sales Market Share Geographic Region (2017-2022)
Table 27. Global Belimumab Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Belimumab Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Belimumab Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Belimumab Sales Market Share by Country/Region (2017-2022)
Table 31. Global Belimumab Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Belimumab Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Belimumab Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Belimumab Sales Market Share by Country (2017-2022)
Table 35. Americas Belimumab Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Belimumab Revenue Market Share by Country (2017-2022)
Table 37. Americas Belimumab Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Belimumab Sales Market Share by Type (2017-2022)
Table 39. Americas Belimumab Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Belimumab Sales Market Share by Application (2017-2022)
Table 41. APAC Belimumab Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Belimumab Sales Market Share by Region (2017-2022)
Table 43. APAC Belimumab Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Belimumab Revenue Market Share by Region (2017-2022)
Table 45. APAC Belimumab Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Belimumab Sales Market Share by Type (2017-2022)
Table 47. APAC Belimumab Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Belimumab Sales Market Share by Application (2017-2022)
Table 49. Europe Belimumab Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Belimumab Sales Market Share by Country (2017-2022)
Table 51. Europe Belimumab Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Belimumab Revenue Market Share by Country (2017-2022)
Table 53. Europe Belimumab Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Belimumab Sales Market Share by Type (2017-2022)
Table 55. Europe Belimumab Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Belimumab Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Belimumab Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Belimumab Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Belimumab Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Belimumab Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Belimumab Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Belimumab Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Belimumab Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Belimumab Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Belimumab
Table 66. Key Market Challenges & Risks of Belimumab
Table 67. Key Industry Trends of Belimumab
Table 68. Belimumab Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Belimumab Distributors List
Table 71. Belimumab Customer List
Table 72. Global Belimumab Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Belimumab Sales Market Forecast by Region
Table 74. Global Belimumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Belimumab Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Belimumab Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Belimumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Belimumab Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Belimumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Belimumab Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Belimumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Belimumab Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Belimumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Belimumab Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Belimumab Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Belimumab Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Belimumab Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Belimumab Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Belimumab Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Belimumab Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Belimumab Revenue Market Share Forecast by Application (2023-2028)
Table 92. GlaxoSmithKline Basic Information, Belimumab Manufacturing Base, Sales Area and Its Competitors
Table 93. GlaxoSmithKline Belimumab Product Offered
Table 94. GlaxoSmithKline Belimumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. GlaxoSmithKline Main Business
Table 96. GlaxoSmithKline Latest Developments
List of Figures
Figure 1. Picture of Belimumab
Figure 2. Belimumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Belimumab Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Belimumab Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Belimumab Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 400mg Injection
Figure 10. Product Picture of 120mg Injection
Figure 11. Global Belimumab Sales Market Share by Type in 2021
Figure 12. Global Belimumab Revenue Market Share by Type (2017-2022)
Figure 13. Belimumab Consumed in Hospital
Figure 14. Global Belimumab Market: Hospital (2017-2022) & (K Pcs)
Figure 15. Belimumab Consumed in Drug Center
Figure 16. Global Belimumab Market: Drug Center (2017-2022) & (K Pcs)
Figure 17. Belimumab Consumed in Clinic
Figure 18. Global Belimumab Market: Clinic (2017-2022) & (K Pcs)
Figure 19. Belimumab Consumed in Other
Figure 20. Global Belimumab Market: Other (2017-2022) & (K Pcs)
Figure 21. Global Belimumab Sales Market Share by Application (2017-2022)
Figure 22. Global Belimumab Revenue Market Share by Application in 2021
Figure 23. Belimumab Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Belimumab Revenue Market Share by Company in 2021
Figure 25. Global Belimumab Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Belimumab Revenue Market Share by Geographic Region in 2021
Figure 27. Global Belimumab Sales Market Share by Region (2017-2022)
Figure 28. Global Belimumab Revenue Market Share by Country/Region in 2021
Figure 29. Americas Belimumab Sales 2017-2022 (K Pcs)
Figure 30. Americas Belimumab Revenue 2017-2022 ($ Millions)
Figure 31. APAC Belimumab Sales 2017-2022 (K Pcs)
Figure 32. APAC Belimumab Revenue 2017-2022 ($ Millions)
Figure 33. Europe Belimumab Sales 2017-2022 (K Pcs)
Figure 34. Europe Belimumab Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Belimumab Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Belimumab Revenue 2017-2022 ($ Millions)
Figure 37. Americas Belimumab Sales Market Share by Country in 2021
Figure 38. Americas Belimumab Revenue Market Share by Country in 2021
Figure 39. United States Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Belimumab Sales Market Share by Region in 2021
Figure 44. APAC Belimumab Revenue Market Share by Regions in 2021
Figure 45. China Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Belimumab Sales Market Share by Country in 2021
Figure 52. Europe Belimumab Revenue Market Share by Country in 2021
Figure 53. Germany Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Belimumab Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Belimumab Revenue Market Share by Country in 2021
Figure 60. Egypt Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Belimumab Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Belimumab in 2021
Figure 66. Manufacturing Process Analysis of Belimumab
Figure 67. Industry Chain Structure of Belimumab
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
